Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

VolitionRx Limited

VNRX•AMEX
Healthcare
Medical - Diagnostics & Research
$0.20
$0.007(3.80%)
U.S. Market opens in 17h 11m

VolitionRx Limited (VNRX) Stock Overview

Explore VolitionRx Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap19.3M
P/E Ratio-0.94
EPS (TTM)$-0.23
ROE0.77%
Fundamental Analysis

AI Price Forecasts

1 Month$0.25
3 Months$0.00
1 Year Target$0.28

VNRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of VolitionRx Limited (VNRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 31.94, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.28.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.94 and a market capitalization of 19.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.08%
5-Day Change
-12.09%
1-Month Change
-31.42%
3-Month Change
-39.94%
6-Month Change
-71.89%
Year-to-Date (YTD) Change
-29.16%
1-Year Change
-65.59%
3-Year Change
-89.49%
5-Year Change
-95.46%
All-Time (Max) Change
-93.55%

Contact Information

https://www.volition.com
646 650 1351
13215 Bee Cave Parkway, Henderson, TX, 78738

Company Facts

850 Employees
IPO DateMar 2, 2012
CountryUS
Actively Trading

Frequently Asked Questions